The TIDES Europe: Oligonucleotide & Peptide Therapeutics is the Industry’s leading even in Europe to Accelerate Therapeutics to market by expediting R&D, Improving CMC Efficiency, and Building New Partnerships. The TIDES Europe 2024 hybrid program features scientific tracks covering in-depth development strategies, trends and technologies across the entire oligonucleotide and peptide spectrum and areas of focus such as: Oligonucleotide Chemistry, Manufacturing & controls, Oligonucleotide Discovery, Preclinical and Clinical, Peptide Chemistry, Manufacturing & controls, Peptide Discovery, Preclinical and Clinical, mRNA Therapeutics and Genome Editing, and Macromolecular Drug Delivery.

This year’s meeting will be a big event for ADS Biotec, providing an opportunity for collaboration, learning, and celebration. Here’s a sneak peek of what’s in store:

• Kick-off: Let’s celebrate our wins and share some opportunities as we reflect on the highlights of the past year.
• New products: Visit our Booth to find out about our New Products

More details to follow! Come and visit us at our booth!
November 12-14, 2024 in Hamburg Germany